Universitaire Ziekenhuizen Leuven
🇧🇪Belgium
Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk Primary Operable Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2014-12-09
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Target Recruit Count
- 117
- Registration Number
- NCT00256360
- Locations
- 🇧🇪
UZ Gasthuisberg Leuven, Leuven, Belgium
© Copyright 2025. All Rights Reserved by MedPath